Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ProMedDx

ProMedDx
1998 FOUNDED
M&A STATUS
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Owner and operator of a contract research company intended to deliver the human biologics and supporting clinical services. The company offers annotated biospecimens and related services including patient recruitment, prospective specimen collection, biospecimen procurement, bioprocessing, biostorage and clinical study monitoring, enabling biobanking industry to access their services for global biospecimen management and direct-to-patient connection.

Formerly Known As
BioQual International
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Parent Company
Primary Office
  • 10 Commerce Way
  • Norton, MA 02766
  • United States

+1 (508) 000-0000

ProMedDx Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore ProMedDx‘s full profile, request access.

Request full access to PitchBook

ProMedDx Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Charles River Laboratories International Formerly PE-Backed Wilmington, MA 00000 00000 000000000000 00000
0000000 0000000000 Corporate Backed or Acquired Vienna, VA 00 000000&0
To view this company’s complete list of competitors, request access »

ProMedDx Executive Team (2)

Name Title Board
Seat
Contact
Info
Jim Boushell Co-Founder & Chief Executive Officer
Jim Sperzel Co-Founder & Chief Operating Officer